By Brittany Sood and Richard Whitten
CoQ10 is not FDA-approved to treat any medical condition although it is widely available over-the-counter as a dietary supplement and recommended by primary care physicians and specialists alike. Diseases such as neurodegenerative diseases, fibromyalgia, diabetes, cancer, mitochondrial diseases, muscular diseases, and heart failure are associated with decreased circulating levels of CoQ10. Many studies have been performed on the premise that increasing systemic CoQ10 levels in such conditions would allow for the proper functioning of processes that require CoQ10.
A recently published, systematic review demonstrated that supplementation with CoQ10 in addition to standard therapy in patients with moderate-to-severe heart failure is associated with symptom reduction as well as reduction of major adverse cardiovascular events. It may also improve functional capacity, endothelial function, and left ventricle contractility in patients with congestive heart failure.
Supplementation has shown promising results in improving endothelial function in several subsets of patients. It has been shown to improve endothelial function in patients with ischemic left ventricular systolic dysfunction heart failure. Likewise, when compared with placebo, CoQ10 appears to improve endothelial function in the peripheral circulation of type-2 diabetics with hyperlipidemia. Nonetheless, evidence on the routine use of CoQ10 in patients with coronary artery disease apart from congestive heart failure is still scanty.
There is also some evidence that, when combined with selenium, CoQ10 supplementation in healthy elderly patients as well as elderly patients with diabetes, hypertension, and ischemic heart disease, may decrease cardiovascular mortality risk. At this point, data is conflicting as to whether CoQ10 may play a role in treating high blood pressure.
CoQ10 has shown the potential to decrease pain, fatigue, and morning tiredness compared to placebo in patients with fibromyalgia.
Some data suggest that supplementation with moderate-to-high dose CoQ10 in patients with mitochondrial disorders may have a minor effect on bicycle exercise aerobic capacity.
Supplementation with 300 mg daily for 24 weeks in men with Peyronie disease may decrease penile plaque size, reduce penile curvature, and improve erectile function.
Statin drugs, of note, block the production of an intermediate in the mevalonate pathway, a biochemical pathway that leads to the production of CoQ10. Therefore, many physicians hypothesize that statin drugs may deplete the body of CoQ10. As muscle pain and cramping is such a common adverse effect of statins, they believe this depletion is the culprit. Supplementation with 50 mg twice daily has shown the ability to decrease statin-related mild-to-moderate myalgias, resulting in an increased ability to perform daily activities.
Although most studies have used patients with preexisting medical conditions, one study of healthy participants did show that oral supplementation improved subjective fatigue and physical performance during bicycle exercise routines.
CoQ10 has also shown promise in migraine prophylaxis. A double-blind randomized controlled trial showed 300 mg daily to be safe and superior to placebo for migraine prevention. Another randomized double-blind placebo-controlled trial in a cohort of adult women showed that supplementation of 400 mg per day decreased migraine frequency, severity, and duration. A cohort study of 1550 children and adolescents with headaches found that this population tends to have low CoQ10 levels. Furthermore, supplementation appeared to decrease headache frequency. One study showed that the use of only 100 mg daily decreased the severity of headaches and the number of headaches per month in migraine sufferers. 
Interestingly, CoQ10 levels appear to be decreased in those with acute influenza infection. Studies on supplementation in this subset of patients has yet to be done, however.
When supplemented alongside standard psychiatric medical therapy, CoQ10 appears to lessen symptoms of depression in patients with bipolar disorder.
In patients with polycystic ovary syndrome, supplementation may improve fasting blood glucose, insulin levels, and total testosterone levels.
Mechanism of Action
Coenzyme Q10 (CoQ10), also referred to as ubiquinone, is a fat-soluble, vitamin-like molecule found naturally in every cellular membrane in our bodies. It is a normal part of our diet but is also endogenously synthesized. It is essential for the proper transfer of electrons within the mitochondrial oxidative respiratory chain as well as adenosine triphosphate (ATP) production. It has been shown to increase the production of key antioxidants such as superoxide dismutase, an enzyme capable of reducing vascular oxidative stress in hypertensive patients. CoQ10 reduces levels of lipid peroxidation via the reduction of pro-oxidative compounds. CoQ10 can enhance blood flow and protect blood vessels via the preservation of nitric oxide.
Supplements offer CoQ10 in either the oxidized form (ubiquinone) or the reduced form (ubiquinol). The bioavailability of a given CoQ10 supplement appears to be dependent on the lipid carrier it is immersed in as well as any preservatives added.
The vast majority of studies done on CoQ10 in humans have only evaluated it as an oral supplement. Topical over-the-counter preparations are also available, but studies on this route of administration are limited. One study does investigate a topical preparation as a treatment for age-related, skin oxidative damage.
Coenzyme Q10 supplements are generally well-tolerated with only minor and infrequent adverse effects, which may include stomach upset, nausea, vomiting, and diarrhea. Doses of 100 mg per day or higher have been associated with mild insomnia in some individuals. Liver enzyme elevation has been seen in some patients taking 300 mg or more per day, but no liver toxicity has been reported. Supplementation has been shown to be tolerated, even up to 1200 mg/day. Other rare adverse effects have included dizziness, photophobia, irritability, headache, heartburn, and fatigue.
Dietary supplements such as coenzyme Q10 are unfortunately not strictly regulated by the FDA nor are manufacturers required to prove their safety and purity before they are released into the market.
Subscribe to the World's Most Popular Fibromyalgia Newsletter (it's free!)
However, several independent agencies visit supplement manufacturing facilities and test supplements for purity, composition, and strength and issue certifications to manufacturers that meet their testing criteria. These agencies do not test every batch that is manufactured, however, and they do not guarantee therapeutic value. Often, manufacturers that have received these agencies’ seal of approval will advertise so on their product packaging.
Studies are limited on CoQ10 use in patients with kidney and liver disease, and therefore, it should be avoided in these patients. Patients using chemotherapeutic drugs should avoid using CoQ10 as well since there is little data on the interaction of CoQ10 with these drugs. Since CoQ10 has been shown to lower fasting blood glucose in some patients, it should be used with caution in those with diabetes and/or patients who are prone to hypoglycemic episodes. CoQ10 use should be avoided in nursing mothers, children, and infants as studies in these populations are lacking.
Many studies have monitored blood levels of CoQ10 to assess the efficacy of supplementation. Average plasma concentrations appear to be about 0.34 to 1.65 micrograms/mL. A toxic blood CoQ10 level has not been determined, mostly because CoQ10 toxicity has not been seen, even at the highest oral supplementation levels.
CoQ10 is extremely safe as a dietary supplement. Toxicity has not been seen, even up to a daily intake of 1,200 mg/day, although typical dosages studied have been 100 to 200 mg/day.
Enhancing Healthcare Team Outcomes
Coenzyme Q10 is a safe, popular dietary supplement that is continuously being studied as an adjunctive treatment for a variety of medical conditions. With the broad commercial base of the supplement industry and widespread interest in complementary and alternative medicine in the United States, it is inevitable that many healthcare professionals will encounter patients who are interested in using it as well as other dietary supplements. As data on this promising supplement continues to grow, it is essential that physicians, nurses, pharmacists, and other healthcare professionals continue to update themselves on its potential as an adjunctive treatment for a variety of medical conditions.
Potential Level I evidence for the use of CoQ10 includes adjunctive treatment for patients with moderate-to-severe congestive heart failure.
Potential Level II evidence includes CoQ10 supplementation for the following indications:
- To improve endothelial function in patients with ischemic left ventricular systolic dysfunction heart failure
- To improve endothelial function in the peripheral circulation of type-2 diabetics with hyperlipidemia
- To decrease pain, fatigue, and morning tiredness in patients with fibromyalgia
- To improve aerobic capacity in patients with mitochondrial disorders
- To decrease penile plaque size, reduce penile curvature, and improve erectile function in patients with Peyronie disease
- To decrease statin-related mild-to-moderate myalgias
- To improve subjective fatigue and physical performance during bicycling exercise routines in healthy patients
- To lessen symptoms of depression in patients with bipolar disorder alongside conventional pharmacologic therapy
- To improve fasting blood glucose, insulin levels, and total testosterone levels in patients with polycystic ovary syndrome
- To decrease migraine frequency in adult migraine sufferers 
Potential Level III evidence for the use of CoQ10 includes the following indications:
- To reduce cardiovascular mortality risk along with selenium administration in healthy elderly patients
- To decrease the severity of headaches and the number of headaches per month in adult and pediatric migraine sufferers
To access free multiple choice questions on this topic, click here.
You can find additional information about CoQ10 in the following articles:
- The Crucial Role CoQ10 Plays In Fibromyalgia And ME/CFS
- Adding CoQ10 To Mediterranean Diet Improves Post-Meal Metabolic State
- CoQ10’S Potential Capabilities For Your Health
- CoQ10 — A Nutritional Powerhouse For Mitochondrial Health
- Coenzyme Q10 (CoQ10) For Fibromyalgia, ME/CFS And Migraine
To purchase CoQ10, visit the ProHealth Shop.
Source: Brittany Sood and Richard Whitten. Coenzyme Q10. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
- Chase M, Cocchi MN, Liu X, Andersen LW, Holmberg MJ, Donnino MW. Coenzyme Q10 in acute influenza. Influenza Other Respir Viruses. 2018 Aug 29; [PubMed]
- López-Lluch G, Del Pozo-Cruz J, Sánchez-Cuesta A, Cortés-Rodríguez AB, Navas P. Bioavailability of coenzyme Q10 supplements depends on carrier lipids and solubization. 2018 Jun 27;57:133-140.[PubMed]
- Jafari M, Mousavi SM, Asgharzadeh A, Yazdani N. Coenzyme Q10 in the treatment of heart failure: A systematic review of systematic reviews. Indian Heart J. 2018 Jul;70 Suppl 1:S111-S117. [PMC free article] [PubMed]
- Zaleski AL, Taylor BA, Thompson PD. Coenzyme Q10 as Treatment for Statin-Associated Muscle Symptoms-A Good Idea, but…. Adv Nutr. 2018 Jul 01;9(4):519S-523S. [PMC free article] [PubMed]
- Ayers J, Cook J, Koenig RA, Sisson EM, Dixon DL. Recent Developments in the Role of Coenzyme Q10 for Coronary Heart Disease: A Systematic Review. Curr Atheroscler Rep. 2018 May 16;20(6):29. [PubMed]
- Bhatt KN, Butler J. Myocardial Energetics and Heart Failure: a Review of Recent Therapeutic Trials. Curr Heart Fail Rep. 2018 Jun;15(3):191-197. [PubMed]
- Zozina VI, Covantev S, Goroshko OA, Krasnykh LM, Kukes VG. Coenzyme Q10 in Cardiovascular and Metabolic Diseases: Current State of the Problem. Curr Cardiol Rev. 2018;14(3):164-174. [PMC free article] [PubMed]
- Cordero MD, Santos-García R, Bermejo-Jover D, Sánchez-Domínguez B, Jaramillo-Santos MR, Bullón P. Coenzyme Q10 in salivary cells correlate with blood cells in Fibromyalgia: improvement in clinical and biochemical parameter after oral treatment. Clin. Biochem. 2012 Apr;45(6):509-11. [PubMed]
- Garrido-Maraver J, Cordero MD, Oropesa-Ávila M, Fernández Vega A, de la Mata M, Delgado Pavón A, de Miguel M, Pérez Calero C, Villanueva Paz M, Cotán D, Sánchez-Alcázar JA. Coenzyme q10 therapy. Mol Syndromol. 2014 Jul;5(3-4):187-97. [PMC free article] [PubMed]
- Du J, Wang T, Huang P, Cui S, Gao C, Lin Y, Fu R, Shen J, He Y, Tan Y, Chen S. Clinical correlates of decreased plasma coenzyme Q10 levels in patients with multiple system atrophy. Parkinsonism Relat. Disord. 2018 Jul 26; [PubMed]
- Belardinelli R, Muçaj A, Lacalaprice F, Solenghi M, Seddaiu G, Principi F, Tiano L, Littarru GP. Coenzyme Q10 and exercise training in chronic heart failure. Eur. Heart J. 2006 Nov;27(22):2675-81. [PubMed]
- Dai YL, Luk TH, Yiu KH, Wang M, Yip PM, Lee SW, Li SW, Tam S, Fong B, Lau CP, Siu CW, Tse HF. Reversal of mitochondrial dysfunction by coenzyme Q10 supplement improves endothelial function in patients with ischaemic left ventricular systolic dysfunction: a randomized controlled trial. Atherosclerosis. 2011 Jun;216(2):395-401. [PubMed]
- Watts GF, Playford DA, Croft KD, Ward NC, Mori TA, Burke V. Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus. Diabetologia. 2002 Mar;45(3):420-6. [PubMed]
- Alehagen U, Aaseth J, Alexander J, Johansson P. Still reduced cardiovascular mortality 12 years after supplementation with selenium and coenzyme Q10 for four years: A validation of previous 10-year follow-up results of a prospective randomized double-blind placebo-controlled trial in elderly. PLoS ONE. 2018;13(4):e0193120. [PMC free article] [PubMed]
- Wong AP, Kassab YW, Mohamed AL, Abdul Qader AM. Review: Beyond conventional therapies: Complementary and alternative medicine in the management of hypertension: An evidence-based review. Pak J Pharm Sci. 2018 Jan;31(1):237-244. [PubMed]
- Cordero MD, Alcocer-Gómez E, de Miguel M, Culic O, Carrión AM, Alvarez-Suarez JM, Bullón P, Battino M, Fernández-Rodríguez A, Sánchez-Alcazar JA. Can coenzyme q10 improve clinical and molecular parameters in fibromyalgia? Antioxid. Redox Signal. 2013 Oct 20;19(12):1356-61. [PubMed]
- Cordero MD, Alcocer-Gómez E, de Miguel M, Cano-García FJ, Luque CM, Fernández-Riejo P, Fernández AM, Sánchez-Alcazar JA. Coenzyme Q(10): a novel therapeutic approach for Fibromyalgia? case series with 5 patients. Mitochondrion. 2011 Jul;11(4):623-5. [PubMed]
- Glover EI, Martin J, Maher A, Thornhill RE, Moran GR, Tarnopolsky MA. A randomized trial of coenzyme Q10 in mitochondrial disorders. Muscle Nerve. 2010 Nov;42(5):739-48. [PubMed]
- Safarinejad MR. Safety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie’s disease: a double-blind, placebo-controlled randomized study. Int. J. Impot. Res. 2010 Sep-Oct;22(5):298-309. [PubMed]
- Skarlovnik A, Janić M, Lunder M, Turk M, Šabovič M. Coenzyme Q10 supplementation decreases statin-related mild-to-moderate muscle symptoms: a randomized clinical study. Med. Sci. Monit. 2014 Nov 06;20:2183-8.[PMC free article] [PubMed]
- Mizuno K, Tanaka M, Nozaki S, Mizuma H, Ataka S, Tahara T, Sugino T, Shirai T, Kajimoto Y, Kuratsune H, Kajimoto O, Watanabe Y. Antifatigue effects of coenzyme Q10 during physical fatigue. Nutrition. 2008 Apr;24(4):293-9. [PubMed]
- Shoeibi A, Olfati N, Soltani Sabi M, Salehi M, Mali S, Akbari Oryani M. Effectiveness of coenzyme Q10 in prophylactic treatment of migraine headache: an open-label, add-on, controlled trial. Acta Neurol Belg. 2017 Mar;117(1):103-109. [PubMed]
- Mehrpooya M, Yasrebifar F, Haghighi M, Mohammadi Y, Jahangard L. Evaluating the Effect of Coenzyme Q10 Augmentation on Treatment of Bipolar Depression: A Double-Blind Controlled Clinical Trial. J Clin Psychopharmacol. 2018 Oct;38(5):460-466. [PubMed]
- Izadi A, Ebrahimi S, Shirzai S, Taghizadeh S, Parizad M, Farzadi L, Pourghassem Gargari B. Hormonal and Metabolic Effects of Coenzyme Q10 and/or Vitamin E in Patients with Polycystic Ovary Syndrome. J. Clin. Endocrinol. Metab. 2018 Sep 07; [PubMed]
- Schniertshauer D, Müller S, Mayr T, Sonntag T, Gebhard D, Bergemann J. Accelerated Regeneration of ATP Level after Irradiation in Human Skin Fibroblasts by Coenzyme Q10. Photochem. Photobiol. 2016 May;92(3):488-94. [PubMed]
- Kędziora-Kornatowska K, Czuczejko J, Motyl J, Szewczyk-Golec K, Kozakiewicz M, Pawluk H, Kędziora J, Błaszczak R, Banach M, Rysz J. Effects of coenzyme Q10 supplementation on activities of selected antioxidative enzymes and lipid peroxidation in hypertensive patients treated with indapamide. A pilot study. Arch Med Sci. 2010 Aug 30;6(4):513-8. [PMC free article] [PubMed]
- Cordero MD, Cano-García FJ, Alcocer-Gómez E, De Miguel M, Sánchez-Alcázar JA. Oxidative stress correlates with headache symptoms in fibromyalgia: coenzyme Q₁₀ effect on clinical improvement. PLoS ONE. 2012;7(4):e35677. [PMC free article] [PubMed]
- Knott A, Achterberg V, Smuda C, Mielke H, Sperling G, Dunckelmann K, Vogelsang A, Krüger A, Schwengler H, Behtash M, Kristof S, Diekmann H, Eisenberg T, Berroth A, Hildebrand J, Siegner R, Winnefeld M, Teuber F, Fey S, Möbius J, Retzer D, Burkhardt T, Lüttke J, Blatt T. Topical treatment with coenzyme Q10-containing formulas improves skin’s Q10 level and provides antioxidative effects. Biofactors. 2015 Nov-Dec;41(6):383-90.[PMC free article] [PubMed]
- Drugs and Lactation Database (LactMed) [Internet]. National Library of Medicine (US); Bethesda (MD): 2006. Coenzyme Q10.
- Baggio E, Gandini R, Plancher AC, Passeri M, Carmosino G. Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure. CoQ10 Drug Surveillance Investigators. Mol. Aspects Med. 1994;15 Suppl:s287-94. [PubMed]
- PDQ Integrative, Alternative, and Complementary Therapies Editorial Board. PDQ Cancer Information Summaries [Internet]. National Cancer Institute (US); Bethesda (MD): Aug 22, 2018. Coenzyme Q10 (PDQ®): Health Professional Version.
- Feigin A, Kieburtz K, Como P, Hickey C, Claude K, Abwender D, Zimmerman C, Steinberg K, Shoulson I. Assessment of coenzyme Q10 tolerability in Huntington’s disease. Mov. Disord. 1996 May;11(3):321-3.[PubMed]
- Hidaka T, Fujii K, Funahashi I, Fukutomi N, Hosoe K. Safety assessment of coenzyme Q10 (CoQ10). Biofactors. 2008;32(1-4):199-208. [PubMed]
- Sándor PS, Di Clemente L, Coppola G, Saenger U, Fumal A, Magis D, Seidel L, Agosti RM, Schoenen J. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology. 2005 Feb 22;64(4):713-5. [PubMed]
- Dahri M, Tarighat-Esfanjani A, Asghari-Jafarabadi M, Hashemilar M. Oral coenzyme Q10 supplementation in patients with migraine: Effects on clinical features and inflammatory markers. Nutr Neurosci. 2018 Jan 03;:1-9.[PubMed]
- Hershey AD, Powers SW, Vockell AL, Lecates SL, Ellinor PL, Segers A, Burdine D, Manning P, Kabbouche MA. Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache. 2007 Jan;47(1):73-80. [PubMed]